These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3306277)

  • 1. Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects.
    Sarlund H; Laakso M; Pyörälä K; Penttilä I
    Metabolism; 1987 Sep; 36(9):840-5. PubMed ID: 3306277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Metabolism; 1985 Aug; 34(8):715-20. PubMed ID: 3894877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Atherosclerosis; 1985 Sep; 56(3):271-81. PubMed ID: 3902037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels.
    Uusitupa M; Siitonen O; Voutilainen E; Aro A; Hersio K; Pyörälä K; Penttilä I; Ehnholm C
    Diabetes Care; 1986; 9(1):17-22. PubMed ID: 3081307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.
    Christiansen E; Schnider S; Palmvig B; Tauber-Lassen E; Pedersen O
    Diabetes Care; 1997 May; 20(5):881-7. PubMed ID: 9135961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
    Laakso M; Pyörälä K; Voutilainen E; Marniemi J
    Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
    Garg A; Grundy SM; Koffler M
    Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
    Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
    Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
    Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
    Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
    Vessby B; Boberg M; Hellsing K; Lithell H; Berne C
    Diabetes Res; 1989 Nov; 12(3):109-16. PubMed ID: 2699585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of endogenous hyperinsulinism on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance.
    Jiao S; Kameda K; Matsuzawa Y; Kubo M; Nonaka K; Tarui S
    Atherosclerosis; 1986 Jun; 60(3):279-86. PubMed ID: 3730047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Circulation; 1990 Jul; 82(1):27-36. PubMed ID: 2194696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J; Rönnemaa T; Koskinen P
    Ann Clin Res; 1987; 19(3):178-82. PubMed ID: 3314647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does residual insulin secretion (assessed by C-peptide concentration) affect lipid and lipoprotein levels in insulin-dependent diabetes mellitus?
    Winocour PH; Durrington PN; Ishola M; Gordon C; Jeacock J; Anderson DC
    Clin Sci (Lond); 1989 Oct; 77(4):369-74. PubMed ID: 2680233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.